{"id":436693,"title":"Letter to the acting Chairperson and Chief Executive Officer of the Patented Medicine Prices Review Board  - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-01-02","captureTimestamp":"2026-01-02T16:28:36.715000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/health-care-system/pharmaceuticals/costs-prices/letter-acting-chairperson-chief-executive-officer-patented-medicine-prices-review-board.html","snippet":"Letter to the acting Chairperson and Chief Executive Officer of the Patented Medicine Prices Review Board The original letter was sent in French only. November 28, 2022 Dear Ms. Bourassa Forcier: I would like to provide you with perspectives regarding the current consultation on…","rawSnapshotUrl":"/api/snapshots/raw/436693","browseUrl":"https://replay.healtharchive.ca/job-6/20260102162836/https://www.canada.ca/en/health-canada/services/health-care-system/pharmaceuticals/costs-prices/letter-acting-chairperson-chief-executive-officer-patented-medicine-prices-review-board.html#ha_snapshot=436693","mimeType":"text/html","statusCode":200}